[Form 4] IonQ, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Thomas G. Kramer, Chief Financial Officer of IonQ, Inc. reported the sale of 537,880 shares of common stock on 08/06/2025 pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025. The reported weighted average sale price was $41.2804, with individual trades ranging from $40.88 to $43.00. Following these transactions, the reporting person beneficially owns 17,776 shares directly and 5 shares indirectly through a child.

The Form 4 discloses the sale activity and includes an undertaking to provide details on the number of shares sold at each price within the disclosed range upon request.

Positive

• Transaction executed under a Rule 10b5-1 trading plan, indicating pre-established trading instructions
• Weighted average price and full trade range disclosed ($41.2804 weighted avg; $40.88–$43.00 range), enhancing transparency
• Reporting person offers to provide per-trade allocation details upon request

Negative

• Large insider sale reported: 537,880 shares were sold, which may be viewed as significant by some investors
• Substantial reduction in direct holdings: beneficial ownership after the sale is shown as 17,776 shares

Insights

Financial Analyst

TL;DR: Large officer sale disclosed under a 10b5-1 plan; transparent pricing range provided.

The report shows that IonQ's CFO executed a planned sale of 537,880 shares under a Rule 10b5-1 trading plan adopted March 14, 2025, at a reported weighted average of $41.2804 and an execution price range of $40.88–$43.00. The filing states the reporting person retains 17,776 shares directly and 5 shares indirectly. From an analytics perspective, this is a clear disclosure of insider liquidity rather than an operational or financial performance update. The filing includes an explicit offer to provide per-price allocation details, which supports transparency for investors or regulators requesting granularity.

Corporate Governance Expert

TL;DR: Insider sale followed a documented 10b5-1 plan, showing procedural compliance and added transparency.

The Form 4 indicates the sale was executed pursuant to a Rule 10b5-1 plan, which is a commonly used mechanism for pre-scheduled insider transactions. The footnote discloses the plan adoption date and provides a weighted average price plus the full trade price range ($40.88–$43.00), and the reporting person commits to furnish per-trade counts on request. These elements reflect adherence to routine disclosure and documentation practices under Section 16 reporting obligations. The filing does not include any additional corporate governance actions or changes in role.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kramer Thomas G.

(Last) (First) (Middle)

C/O IONQ, INC.

4505 CAMPUS DRIVE

(Street)

COLLEGE PARK MD 20740

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IonQ, Inc. [ IONQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/06/2025		S(1)		17,776	D	$41.2804(2)	537,880	D
Common Stock								5	I	By child

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.88 to $43.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Kevin Caimi, Attorney-in-Fact	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did IonQ (IONQ) CFO Thomas G. Kramer report on Form 4?

The CFO reported the sale of 537,880 shares of common stock on 08/06/2025 under a Rule 10b5-1 plan.

At what price were the IonQ shares sold in the Form 4 filing?

The filing reports a weighted average sale price of $41.2804, with trades executed in the range of $40.88 to $43.00.

When was the 10b5-1 plan that governed the sale adopted?

The Form 4 states the Rule 10b5-1 trading plan was adopted on March 14, 2025.

How many IonQ shares does the reporting person own after the reported transactions?

Following the reported sale, the reporting person beneficially owns 17,776 shares directly and 5 shares indirectly through a child.

Will more details on the specific trades be available?

Yes. The reporting person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the disclosed range.